Cellectar Biosciences Inc (CLRB) reported a net loss of $21.58 million for the first quarter.
The loss translates to $0.74 per share, compared to a net loss of $8.58 million or $0.76 per share in the same period last year.
Summary of Cellectar Biosciences Inc's Q1 earnings (GAAP):
- Net Loss: $21.58 million, up from $8.58 million last year
- EPS: -$0.74, compared to -$0.76 last year
